Put companies on watchlist
Aspermont Ltd.
ISIN: AU000000ASP3
WKN: A0NGFS
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Aspermont Ltd. · ISIN: AU000000ASP3 · EQS - Analysts (23 News)
Country: Germany · Primary market: Australia · EQS NID: 20985
04 October 2024 10:01AM

Buy


Original-Research: Aspermont Ltd. - from GBC AG

04.10.2024 / 10:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of GBC AG to Aspermont Ltd.

Company Name: Aspermont Ltd.
ISIN: AU000000ASP3
 
Reason for the research: Research Report (Note)
Recommendation: Buy
Last rating change: 0.07 AUD
Analyst: Julien Desrosiers, Matthias Greiffenberger

Resurgence in Growth Following Challenging 2024 Half-Year Results. Strategic Recruitment of Renowned Top Executives and Leadership. Forecast Prioritizes Quality Revenue.

Rebound After a Challenging H1 2024: Despite early setbacks, Aspermont capitalized on its strategic investments in high-growth sectors to achieve a strong performance turnaround.

Strong Cash Position: The company maintains a healthy net liquidity of $1.3 million as of Q3 2024.

Year-on-Year Revenue Growth: Total revenue for Q3 2024 rose to $5.0 million, marking a 20% increase compared to the previous year.

Competitive Advantage: While competitors have faced significant losses in recent quarters, Aspermont's robust performance underscores its position of strength.

Operational Agility: Aspermont’s decentralized structure and scalable workforce continue to be key strengths, enabling swift product launches while managing investment risks, as evidenced by the increase in net asset liquidity.

Completing technological turnaround: The company will be shifting from revenue quantity to revenue quality in order to reach net profit equilibrium and start posting posting profits in FY2025.

Based on our DCF model, we revise our price target to AUD 0.03 / 0.02 EUR per share (down from AUD 0.07) and maintain a buy rating.



You can download the research here: http://www.more-ir.de/d/30985.pdf

Contact for questions:
GBC AG
Halderstraße 27
86150 Augsburg
0821 / 241133 0
research@gbc-ag.de
++++++++++++++++
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG und Art. 20 MAR Beim oben analysierten Unternehmen ist folgender möglicher Interessenkonflikt gegeben: (5a,7,11); Einen Katalog möglicher Interessenkonflikte finden Sie unter:
https://www.gbc-ag.de/de/Offenlegung
+++++++++++++++
Date and time of completion of this research: 02.10.2024 (03:00 pm)
Date and time of first distribution: 04.10.2024 (10:00 am)


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


2000843  04.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2000843&application_name=news&site_id=boersengefluester_html
Visual performance / price development - Aspermont Ltd.
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.